Amneal Pharmaceuticals Private Limited

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed hormone-sensitive (high risk), low-volume castration-resistant after inadequate therapy, as well as progressing castration-resistant prostate cancer during or after docetaxel chemotherapy.

Dosage form: tablets

ATC: L02BX03

The drug is intended for the treatment of adult patients with relapsing-remitting forms of multiple sclerosis, including clinically isolated syndrome and active secondary progressive disease.

Dosage form: capsules, modified release

ATC: L04AX07